Abstract
We have synthesized water-soluble complexes between the antiviral drug arbidol and polymer compounds with molecular masses of 19–31 kDa representing copolymers of acrylamide (AA) and 2-acrylamido-2-methylpropanesulfonic acid (AAMPS). The complexes are less toxic than arbidol and retain the high level of antiviral activity of this drug. The content of arbidol in the obtained complexes is within 26.4–32.1 mass%. The antiviral activity of the synthesized polymeric complexes against all studied viruses, including human epidemic influenza virus A (H3N2), bird highly pathogenic influenza virus A (H5N1), herpes type 1 virus (HSV-1), and adenovirus type III (AV-III) is comparable to the antiviral effect of nonmodified arbidol. The in vitro toxicity of the obtained complexes is about one order of magnitude lower than that of nonmodified arbidol; the pharmacological index, four times that of the initial low-molecular-weight drug. The synthesized water-soluble polymer complexes of arbidol can be useful in pharmacology since they can serve as the basis for new effective and safe parent antiviral substances and related formulations.
Key words: water-soluble polymer complexes of arbidol, antiviral activity, use in pharmacology
Footnotes
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 43, No. 10, pp. 27–31, October, 2009.
References
- 1.Gus’kova TA, Glushkov RG. Arbidol, Immunomodulator, Interferon Inductor, and Antioxidant. Moscow: TsKhLS-VNIKhFI; 2001. [Google Scholar]
- 2.I. A. Leneva, Author’s Abstract of a Doctoral Dissertation in Biological Sciences, St. Petersburg (2005).
- 3.Leneva IA, Gus’kova TA, Glushkov RG. Khim.-farm. Zh. 2004;38(11):8–14. [Google Scholar]
- 4.Berezovskaya IV. Khim.-farm. Zh. 2003;37(3):32–34. [Google Scholar]
- 5.R. U. Khabriev, ed., Handbook of Experimental (Preclinical) Testing of New Pharmacological Compounds [in Russian], Moscow (2005), pp. 532–557.
- 6.M. V. Solovskii, M. Yu. Eropkin, E. M. Eropkina, et al., Zh. Prikl. Khim., No. 10, 1674–1678 (2007).
- 7.Kiselev OI, Deeva EG, Slita AV, Platonov VG. Antiviral Preparations for Treating Flu and SARS. Design of Preparations Based on Polymeric Carriers. St. Petersburg: Vremya; 2000. [Google Scholar]
- 8.M. Yu. Eropkin, M. V. Solovskii, E. M. Eropkina, and E. L. Shul tseva, Toksikol. Vestn., No. 5, 18–22 (2006).
- 9.Kargin VA, editor. Polymer Encyclopedia. Moscow: Sovetskaya Entsiklopediya; 1972. [Google Scholar]
- 10.Clothier R, Starzec G, Pradel L, et al. ATLA, Altern. Lab. Anim. 2002;30:493–504. doi: 10.1177/026119290203000503. [DOI] [PubMed] [Google Scholar]
- 11.Mosmann T. J. Immunol. Methods. 1983;65(1):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
- 12.Kiselev OI, Blinov VM, Pisareva MM, et al. Mol. Biol. 2008;42(1):78–87. [PubMed] [Google Scholar]